Medications

AstraZeneca suffers diabetes drug setback for COVID

British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.

Diseases, Conditions, Syndromes

Mortality higher for diabetic ketoacidosis with COVID-19

(HealthDay)—Patients with diabetic ketoacidosis (DKA) with COVID-19 have a much higher rate of mortality than patients without COVID-19, according to a research letter published online March 10 in JAMA Network Open.

Diabetes

Albuminuria down in adults with newly diagnosed T2DM

(HealthDay)—From 1988 to 2018, there were reductions seen in the prevalence of albuminuria and improvements in glycemic, blood pressure, and lipid control among adults with newly diagnosed type 2 diabetes, according to ...

page 1 from 17